Fei Xia

Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study

Peng Xu, Rong Hua Tian, Song Luo et al. · Theranostics · 2020 · 141 citations · Full text

Medicine, Radiology, Critical Care Medicine +12

Psychological morbidities and fatigue in patients with confirmed COVID-19 during disease outbreak: prevalence and associated biopsychosocial risk factors

Rongfeng Qi, Wei Chen, Saiduo Liu et al. · medRxiv · 2020 · 90 citations · Full text

Nursing, Infectious Diseases, Psychiatry +17

Resveratrol Inhibits CD4+ T Cell Activation by Enhancing the Expression and Activity of Sirt1

Ting Zou, Yi Yang, Fei Xia et al. · PLoS ONE · 2013 · 89 citations · Full text

Life Sciences, Immunology, Immunopathology +16

Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms

Hongbin Chen, Weiyuan Wu, Ming Ni et al. · International Journal of Antimicrobial Agents · 2013 · 72 citations

Life Sciences, Infectious Diseases, Microbiology +17

Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells

Pei Zhang, Hao Liu, Fei Xia et al. · International Journal of Molecular Medicine · 2013 · 61 citations · Full text

Medicine, Cancer Biology, Oncology +17